Table 1.
Clinical features of the study population n (%)
| Clinical features | Patient (n = 112) |
| Age (mean ± SD) (yr) | 59.67 ± 14.18 |
| Sex | |
| Male | 61 (54.5) |
| Female | 51 (45.5) |
| BMI, mean (SD) (kg/m2) | 23.26 (4.27) |
| DM status | |
| DM | 27 (24.1) |
| Non-DM | 85 (75.9) |
| Disease leading to chronic renal failure | |
| Chronic glomerulonephritis | 40 (35.7) |
| Primary hypertension | 31 (27.7) |
| Diabetes mellitus | 22 (19.6) |
| Polycystic kidney disease | 7 (6.2) |
| Gout | 3 (2.7) |
| Primary hypertension combined with gout | 3 (2.7) |
| Obstructive nephropathy | 2 (1.8) |
| Chronic interstitial nephritis | 1 (0.9) |
| Nephrotic syndrome | 1 (0.9) |
| Ischemic renal disease | 1 (0.9) |
| Microscopic Polyarteritis | 1 (0.9) |
| Steroid history | |
| Yes | 8 (7.1) |
| No | 104 (92.9) |
| Daily dosage of pills, median (interquartile ranges)1 | 12.00 (6.00-21.25) |
| Predialytic GI symptoms | |
| Yes | 14 (12.5) |
| No | 98 (87.5) |
| PD Duration, median (interquartile ranges) (mo)2 | 15.00 (8.00-33.00) |
| Type of PD | |
| CAPD | 60 (53.6) |
| IPD | 50 (44.6) |
| Daily peritoneal dialysate volume (mean ± SD) (L)3 | 7.83 ± 1.28 |
| Albumin (mean ± SD) (g/L)4 | 33.96 ± 4.77 |
| Hemoglobin (mean ± SD) (g/L)5 | 101.24 ± 20.06 |
| Residual renal Kt/V, median (interquartile ranges)6 | 0.39 (0.00-0.82) |
| Peritoneal Kt/V (mean ± SD)6 | 1.51 ± 0.39 |
| Total Kt/V (mean ± SD)6 | 2.00 ± 0.51 |
Restricted to the 106 patients (94.64% of the overall sample) for whom complete information on the daily dosage of pills was available;
Restricted to the 109 patients (97.32% of the overall sample) for whom complete information on peritoneal dialysis duration was available;
Restricted to the 110 patients (98.21% of the overall sample) for whom complete information on peritoneal dialysate volume was available.
Restricted to the 108 patients (96.43% of the overall sample) for whom complete information on serum albumin was available;
Restricted to the 110 patients (98.21% of the overall sample) for whom complete information on serum hemoglobin was available;
Restricted to the 81 patients (72.32% of the overall sample) for whom complete information on residual renal Kt/V, peritoneal Kt/V, and total Kt/V was available. BMI: Body mass index; DM: Diabetes mellitus; CAPD: Continuous ambulatory peritoneal dialysis; IPD: Intermittent peritoneal dialysis; GI: Gastrointestinal; PD: Peritoneal dialysis.